Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic-Phase

Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.

314 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic-Phase trial results

Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

NCT06163430

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations
  • University of Alabama Medicine (UAB Medicine) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Irvine Health Orange, California, United States
  • Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
View all 54 locations
View Trial Details
Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

NCT04838041

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, +12 more
Locations
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

NCT06409936

Conditions
Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +15 more
Locations
  • Hospital del Mar (Barcelona) Barcelona, Spain
  • Hospital Universitario Basurto Bilbao, Spain
  • Institut Català d'Oncologia Girona Girona, Spain
  • Hospital Virgen de las Nieves Granada, Spain
View Trial Details
Recruiting

Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase

NCT06119269

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant Cagliari, Italy
  • Policlinico Milano Milan, Italy
  • University of Naples Federico II - Unit of Hematology Naples, Italy
  • Santa Chiara University Hospital Pisa, Italy
View Trial Details
Recruiting

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

NCT03459534

Conditions
Bone Marrow Diseases, CML - Philadelphia Chromosome, CML, Chronic Phase, +15 more
Locations
  • Territorial State Budgetary Institution Barnaul, Russia
  • Federal State Budgetary Institution of Science Kirov, Russia
  • Federal State Budgetary Institution Moscow, Russia
  • Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin Moscow, Russia
View all 18 locations
View Trial Details

Related conditions